Home » Topics » Conferences

Conferences
RSS

Anti-HIV-1 activity demonstrated in mice by RKS-1443

May 24, 1996

AE6C: AZT prodrug with improved toxicity profile

May 24, 1996

So324: Stavudine prodrug with potent anti-HIV activity

May 24, 1996

New allophenylnorstatine protease inhibitors from Japan Energy

May 24, 1996

RSV inhibitors presented by Wyeth-Ayerst

May 24, 1996

Antiinfluenza activity of LY-180299 described at congress

May 24, 1996

BW-1263W94 selected for clinical testing in CMV infection

May 24, 1996

NF-1153 demonstrates potent activity against influenza virus

May 24, 1996

Japanese researchers present anti-RSV agent at congress

May 24, 1996

NF-1062 evaluated for activity against rotavirus

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.